News By Tag Industry News News By Location Country(s) Industry News
|  In Vitro Diagnostics: Technologies and Global Market reportIn vitro diagnostic tests performed on biological samples, such as blood, urine, saliva, spinal fluid and DNA, are a key component of health care delivery.
By: Bharat Book Bureau The global market for in vitro diagnostics (IVD) products is expected to grow from $60.3 billion in 2015 to $81.1 billion by 2020 at af compound annual growth rate (CAGR) of 6.1% from 2015 to 2020 (https://www.bharatbook.com/ This report provides: -An overview of the global markets and related technologies for in vitro diagnostics -Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020 -Detailed coverage of application areas, end users, and factors influencing and inhibiting demand for IVD Information about IVD products including reagents, instruments, and data management softwares and services -A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for infectious disease testing both in hospitals and laboratories -Segmentation into immunochemistry, clinical chemistry, SMBG, POC, MDx, hematology, microbiology, hemostasis and tissue diagnostics -Geographical breakdowns -Application analysis: Diabetes, infectious, oncology, cardiology, neurology and others. -Profiles of major players in the industry STUDY GOALS AND OBJECTIVES This report offers a comprehensive analysis of the global in-vitro diagnostic market, along with an in-depth study of the various IVD segments (clinical chemistry, immunoassays, point-of-care diagnostics, molecular diagnostics, hematology, microbiology and tissue diagnostics); This report provides a complete review and analysis of the current trends in the IVD markets, along with industry growth drivers and restraints. Revenues are broken down by regions, segments, products and end users, and sales figures have been estimated for the five-year period from 2015 through 2020 in constant U.S. dollars. In addition, it provides an examination and description of select products, current and emerging technologies, and company profiles. Applications for IVD are also discussed, with emphasis of the use of these types of tests in various disease sectors. Further, the report offers a view on IVD patents, regulatory aspects and emerging developments in the IVD market across the globe. REASONS FOR DOING THIS STUDY In vitro diagnostic tests performed on biological samples, such as blood, urine, saliva, spinal fluid and DNA, are a key component of health care delivery. The information provided by IVD tests enable medical care providers to manage several diseases through timely prevention, diagnosis and decision making, and by administering patient-specific treatment modalities. Due to recent rapid technological advances and automation, the range and complexity of diagnostic tests have overwhelmingly increased. This has made lab tests much easier to use and less error prone, with more precise and timelier results, thus transforming medical practice. As a result of these rapid innovations, disease detection has been made possible much before the appearance of symptoms, along with the prediction of beneficial and adverse treatment outcomes. These developments have in turn enabled personalized treatment through the emergence of point-of-care (POC) tests and home-based testing in the form of blood glucose meters for diabetics, pregnancy tests and cholesterol tests. These tests facilitate more rapid decision-making, especially for management of major chronic diseases such as diabetes, hypertension or cardiovascular conditions. Instead of a patient having to wait for test results and schedule his or her next visit, test values for key biochemical parameters (such as, for example, HbA1c or lipid profiles), are generated the same day, allowing a doctor to make treatment decisions during the same visit. In addition, new tests have become less invasive, easier to perform and more patient friendly. Likewise, for critical care, POC tests enable doctors to make life-saving decisions within minutes, as opposed to waiting for hours for test data that was once available only from a central lab. Today, more than 4,000 different diagnostic tests have become available, and as more IVD tests become compatible with POC environments, health care providers should take advantage of the benefits of these evolving IVDs for effective treatment of life-threatening illnesses through optimization of healthcare delivery. IVDs have already tremendously impacted cancer diagnosis and treatment globally by gaining deeper insights into genetic pathways of the disease enabled by human genome sequencing. As a result, identifying faulty genes, personalized risk predictions and tailored therapies have now become possible. For more information kindly visit : https://www.bharatbook.com/ Related Reports : https://www.bharatbook.com/ About Bharat Book Bureau : Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry analysis, country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology. In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself. OR Contact us at : Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Email: info@bharatbook.com Website: www.bharatbook.com End
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number